Learn

Learn of Updates in the Management of Prediabetes and Type II Diabetes

by

OSUWexnerbloglogo2014 Learn of Updates in the Management of Prediabetes and and Type II Diabetes. Learn of Updates in the Management of Prediabetes and and Type II Diabetes. The International Diabetes Federation estimates there are 537 million individuals with diabetes worldwide. And that’s not even counting the patients that go undiagnosed. In the US, we estimate that 1/3 of eligible patients are not screened. Even with screening, there’s a gigantic gap in prediabetes diagnosis and treatment. Those in Primary care are really at the forefront of diabetes & prediabetes care. With 11% of the adult population affected by Diabetes, every healthcare worker must become comfortable with the care and treatment of these patients. So today to help Dr. Mao discuss the updates in the prevention and treatment of diabetes, we’ve invited her colleague Jennifer Sabatino who is a Doctor of Pharmacy and practicing Clinical Pharmacist at Ohio State University. They will cover the basics and updates over the past half a decade or so including both non-pharmacologic and pharmacologic treatment options.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Understand the epidemiology and definition of Prediabetes and Type II diabetes (T2DM).
  • Be familiar with the different treatment options for Prediabetes to prevent progression to T2DM.
  • Understand the pharmacologic and non-pharmacologic treatments for T2DM.
  • Recognize the place in therapy of Glucagon-Like Peptide Receptor Agonists (GLP-1 RA) and Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) for T2DM.
  • Explore a new class of medications for diabetes treatment, the Glucose-Dependent Insulinotropic Polypeptide (GIP)/Glucagon-Like Peptide Receptor Agonist (GLP-1 RA).

You’ll also learn about the following:

  • Supplements
  • Prediabetes treatment Outcomes
  • Pregnancy and lactation

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn about Contraception on CME Webcast

by

OSUWexnerbloglogo2014 Learn About Contraception on CME Webcast. Today there are a lot more options for contraception. So many in fact, that it can be confusing at times which one to use. To review contraception and some of the more recent updates, We’ve invited two of Ohio State University’s experts. First, we have Dr Brett Worly, who is an Associate professor of Obstetrics and Gynecology and a leader of medical education. He has published multiple papers on the relationship between hormonal contraception and mental health. And we also have Hannah Parks who is a Doctor of Nursing Practice and a Pediatric Primary Care Nurse Practitioner.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Feel comfortable counseling patients on different contraception options.
  • Recognize absolute and relative contraindications for contraception.
  • Discuss contraception options for the adolescent population.
  • Be familiar with contraceptive treatments for patient-specific indications

You’ll also learn about the following:

  • Forms of Contraception
  • Birth Control in Adolescents
  • Vaginal Gel
  • Stopping Contraception
  • OCP Selection
  • Bone Density
  • LARC Duration
  • Emergency Contraception

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Psychiatric and Behavioral Health Management in Chronic Health Conditions

by

OSUWexnerbloglogo2014 Learn About Psychiatric and Behavioral Health Management in Chronic Health Conditions. Chronic illnesses are linked with much higher rates of depression and mental illness. But that’s not the only issue. The problem is really bidirectional. Depressed patients with chronic illness, have worse health outcomes. Diabetic patients with depression for example, have lower glycemic control, decreased activity levels, higher weight and higher levels of complication and functional impairment.So today, to discuss the effects of Psychiatric and Behavioral Health Management in Chronic Health Conditions are two of Ohio State University’s Psychiatry experts. Dr. Kevin Johns is an Assistant Professor of Psychiatry who specializes in treating patients with chronic medical problems. He also works to create collaborate care models to help non-psychiatric providers such as myself better address their patient’s mental health needs. Dr. Ashleigh Pona has a PhD in clinical psychology and specializes in bariatric psychology and & eating disorders.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Understand why depression management is an important part of managing general medical conditions.
  • Learn how to diagnose and treat depression in patients with other medical conditions.
  • Teach learners different therapeutic strategies that can be used to manage behavioral health concerns
  • Teach learners why it is important to consider the biopsychosocial model of health in assessing and treating chronic disease

You’ll also learn about the following:

  • Chronic Illness & Depression
  • Telecounseling
  • Mindfulness Apps
  • Mental Health Screening

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Gender Affirming Care on Webcast

by

OSUWexnerbloglogo2014 Learn About Gender Affirming Care on Webcast. Gender affirming care has come a long way in the past century. Here to teach us more about gender affirming care are two of Ohio State University’s experts. We’re pleased to introduce Dr. Andrew Keaster, Assistant Professor of the Department of Family Medicine & Dr. Melissa Davis, Assistant Professor of Family & Community medicine.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to:

  • Review feminizing gender affirming hormone therapy including types of medications used, contraindications, risks, and benefits of treatment.
  • Review masculinizing hormone therapy including contraindications, risks, and benefits of treatment and how this treatment may differ for non-binary individuals.
  • Learn the difference between Sex and Gender
  • Learn to create a safe, supportive space for gender diverse individuals

You’ll also learn about the following:

  • Pronouns
  • Estrogen
  • Young Adults

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Opioid-Sparing Perioperative Care on CME Webcast

by

OSUWexnerbloglogo2014 Learn About Opioid-Sparing Perioperative Care on CME Webcast. 2017 and the US declares the opioid epidemic a public health crisis. The CDC reports 136 people die of opioid overdose every day with synthetic opioids being the most common culprit. Opioids are still a useful tool in our pain management arsenal particularly when we’re putting a patient through a painful procedure—but what else can we use to manage perioperative pain? Here to answer this question and more is Dr Michelle Humeidan, Associate Professor of Anesthesiology at Ohio State University Wexner Medical Center.

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: understand the pathophysiology and diagnosis of acute coronary syndromes; and identify therapies that reduce mortality in acute coronary syndromes.

You’ll also learn about the following:

  • Frequency of Misuse
  • Addiction from short-term use
  • Opioid disposal
  • Preferred Opioids
  • Complementary Medicine
  • Intrathecal Opioids

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.